RT
AXSM icon

Robert Torray’s Axsome Therapeutics AXSM Stock Holding History

Robert Torray’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.65M Buy
14,928
+154
+1% +$33.4K 0.49% 46
2026
Q1 		$2.5M Sell
14,774
-20
-0.1% -$3.46K 0.37% 49
2025
Q4 		$2.7M Sell
14,794
-2,625
-15% -$366K 0.39% 54
2025
Q3 		$2.12M Buy
17,419
+354
+2% +$39.9K 0.29% 59
2025
Q2 		$1.78M Sell
17,065
-51
-0.3% -$5.4K 0.26% 63
2025
Q1 		$2M Sell
17,116
-58
-0.3% -$6.61K 0.3% 66
2024
Q4 		$1.45M Buy
17,174
+5,351
+45% +$492K 0.21% 79
2024
Q3 		$1.06M Buy
11,823
+76
+0.6% +$6.63K 0.15% 88
2024
Q2 		$946K Buy
11,747
+1,209
+11% +$89.5K 0.14% 87
2024
Q1 		$841K Buy
+10,538
New +$885K 0.13% 86

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Robert Torray's AXSM Position: Q2 2026 in Review

Robert Torray increased its Axsome Therapeutics (AXSM) stake by 1% in Q2 2026, buying an estimated $33.4K and bringing the position to 14,928 shares worth $3.65M. The position accounts for 0.49% of the portfolio, ranked #46.

Robert Torray first reported a position in AXSM in Q1 2024 and has held it in 10 quarters since. 502 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Robert Torray held 14,928 shares of Axsome Therapeutics worth $3.65M as of Q2 2026.
  • Robert Torray bought 154 Axsome Therapeutics shares in Q2 2026, an estimated $33.4K.
  • Axsome Therapeutics made up 0.49% of Robert Torray's portfolio in Q2 2026, its #46 holding.
  • Robert Torray first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 502 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Torray Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.